curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  Long-lasting in vivo antibody production: DMAb levels remained stable for 72 weeks in all participants (n=24) who have reached that timepoint No anti-drug…  Long-lasting in vivo antibody production: DMAb levels remained stable for 72 weeks in all participants...
World-first clinical trial shows promise for transformative oral snakebite treatment

World-first clinical trial shows promise for transformative oral snakebite treatment

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  Researchers from Liverpool School of Tropical Medicine (LSTM) have completed a Phase I clinical trial for a new oral treatment for snakebite.  Researchers from Liverpool School of Tropical Medicine (LSTM) have completed a Phase I clinical trial for a new oral...
Combination immunotherapy before surgery may increase survival in people with head and neck cancer: Clinical trial

Combination immunotherapy before surgery may increase survival in people with head and neck cancer: Clinical trial

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs) found that patients responded better to a combination of two immunotherapies …  Researchers conducting a clinical trial of...
Expanded Access Program for recombinant BCG launches at first US site

Expanded Access Program for recombinant BCG launches at first US site

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  There are also 60 sites in the process of launching the EAP.  There are also 60 sites in the process of launching the EAP. 
20/20 Onsite Receives Safety Excellence Award, Reinforcing Commitment to Unmatched Clinical Trial Support

20/20 Onsite Receives Safety Excellence Award, Reinforcing Commitment to Unmatched Clinical Trial Support

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  20/20 Onsite is proud to announce its recognition with the Safety Excellence Award by Whip Around.  20/20 Onsite is proud to announce its recognition with the Safety Excellence Award by Whip Around. 
« Older Entries
Next Entries »

Recent Posts

  • GLOW: Gender-Affirming Care and Mental Health: A Longitudinal Study On Quality of Life, Work Life, and Healthcare Outcomes
  • Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery – a Randomized Controlled Study
  • This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal
  • Improving the Management and Prevention of Perineal Wound Dehiscence From Episiotomies Using Flaminal
  • Evaluation of the Effect of Digital-based Games on the Visual and Cognitive Performance of Young Children With Intellectual Disabilities

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®